Literature DB >> 24118027

Peripheral blood stem cell yield calculated using preapheresis absolute CD34+ cell count, peripheral blood volume processed, and donor body weight accurately predicts actual yield at multiple centers.

Chitra Hosing1, Rima M Saliba, Nelson Hamerschlak, Jose Mauro Kutner, Araci Massami Sakashita, Andrea Tiemi Kondo, Morgani Rodrigues, Juliana Folloni Fernande, Alexandre Chiattone, Viviane C Chiattone, Jose C Barros, Carlos S Chiattone, Ricardo Chiattone, Uday Popat, Muzaffar Qazilbash, Xiao Wen Tang, Depei Wu, Alejandro Majilis, Marcos de Lima, Timoleon Anguita.   

Abstract

BACKGROUND: Accurate prediction of stem cell yield is important for planning leukapheresis procedures. A formula has been published (Pierelli et al., Vox Sang 2006;91:126-34) to estimate the CD34+ dose collected on the first day of leukapheresis that was based on the preapheresis peripheral blood (PB) CD34+ counts, the blood volume processed, and the donor's weight. The aim of this study was to assess the predictive value of this formula. STUDY DESIGN AND METHODS: Data were retrospectively collected on 1126 consecutive PB stem cell harvests conducted at five institutions. Information on age, sex, diagnosis, weight, preapheresis absolute peripheral CD34+ count, total blood volume processed, and CD34+ cells harvested per kilogram of body weight on the first day of apheresis was collected.
RESULTS: Among donors at least 18 years old, Pearson's correlation coefficient (r) between actual yield (AY) and predicted yield (PY) was 0.76. To characterize this correlation, AY and PY were classified as being within the conventionally acceptable CD34+ doses (>2 × 10(6) -5 × 10(6) cells/kg), below this range (≤2 × 10(6) cells/kg), or above it (>5 × 10(6) cells/kg). The positive predictive value (PPV) of PY was estimated considering the distribution of AY as the "gold standard." PPV was relatively high for PY of more than 5 × 10(6) cells/kg (85%), moderate for PY of not more than 2 × 10(6) cells/kg (72%), and low for PY more than 2 × 10(6) to 5 × 10(6) cells/kg (56%). A consistent pattern was observed within institutions.
CONCLUSION: The formula of Pierelli et al. is associated with a PPV that is high, moderate, and relatively low for the corresponding predicted CD34+ doses.
© 2013 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24118027     DOI: 10.1111/trf.12435

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  A simplified CD34+ based preharvest prediction tool for HPC(A) collection.

Authors:  Reuben P Jacob; Scott T Avecilla; Eileen M Walsh; Peter G Maslak; Sergio A Giralt
Journal:  Transfusion       Date:  2021-03-11       Impact factor: 3.337

2.  NF-κB p50-deficient immature myeloid cell (p50-IMC) adoptive transfer slows the growth of murine prostate and pancreatic ductal carcinoma.

Authors:  Rahul Suresh; David J Barakat; Theresa Barberi; Lei Zheng; Elizabeth Jaffee; Kenneth J Pienta; Alan D Friedman
Journal:  J Immunother Cancer       Date:  2020-01       Impact factor: 12.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.